ESLAW

Conviction 18HealthcareScan · Mon, Aug 10, 2026

ESLAW$0.0625+0.00%

ResistanceSupportVol 14

Vol MA14 685

May 8May 27Jun 15Jul 2Jul 22Aug 7

Estrella Immunopharma, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.estrellabio.com ↗

Price0.0625

Change+0.00%

Gap—

Rel volume0.76×

Avg volume818

Avg $ vol59.72

SMA 200.0284

SMA 500.0411

SMA 2000.0420

Price vs 50+52.00%

Price vs 200+48.80%

MA stackmixed

50/200 crossdeath · 2d

Supertrendup · -0.0238

RSI (14)52

MACD hist0.00

MACD crossbull · 5d

Stoch %K / %D60 / 41

ADX (14)7

+DI / −DI54 / 44

RSI divergence—

MACD divergence—

ATR %+84.88%

ADR %15.60%

52w high0.2357

52w low0.0000

From 52w high-73.48%

Above 52w low—

New 52w highNo

SqueezeOn · 2d

Bollinger width500.81%

%B0.74

Donchian pos59.52%

Donchian high0.1050

Donchian low0.0000

AVWAP (52w high)0.0878

vs AVWAP high-28.83%

AVWAP (52w low)0.0777

vs AVWAP low-19.55%

OBV trendUp

Chaikin MF (20)0.08

Today vs 20d0.76×

Avg vol (14d)685

Avg vol (20d)818

Avg $ vol (20d)59.72

Market cap2.69M

RS 3m (vs SPY)-60.24%

RS 6m (vs SPY)-40.67%

RS line new highNo

Trend template2/8

Technical rank61.7

1 week-34.21%

1 month—

3 months-54.55%

6 months-26.56%

1 year+69.84%

YTD—

P/E-0.21

P/B-0.51

P/S—

P/FCF—

EPS-0.3500

Div yield—

ROE247.87%

ROA-357.20%

Debt/Eq—

Current0.24

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-78.67%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.31M

Revenue—

Net income-2.29M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out2.21M

Employees—

ListedMon, Oct 2, 2023

Free float43.03M

Float %100.0%

Short interest29.51K

Days to cover18.4d

Short volume—

Squeeze score31 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank61.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.1418

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ESLAW

All disclosures →

No recent disclosed trades by Congress in ESLAW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ESLAW

No recent insider (Form 4) filings in ESLAW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ESLAW

EDGAR →

No recent SEC filings on file for ESLAW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.